Posted by AGORACOM-JC
at 4:03 PM on Tuesday, January 12th, 2021
Else Nutrition Holdings Inc. (BABY: TSXV) (BABYF: OTCQX) (0YF: FSE) is the award winning, plant-based nutrition company for small cap investors. The shift towards plant-based alternatives has opened the food market to new players, and created an opportunity for fast growth in a rapidly expanding space.
Highlights include:
$CAD 30 Million In Cash
Launched 1st Commercial Product Into US Market
Backed By A $2.7 Billion Dollar Global Nutrition Company;
MOU For International Distribution Of Products
“Best Health” Award At Global Food Innovation Summit In Milan;
Awarded Patents In 22 Countries, 44 Countries Pending;
Executives & Advisors From Globally Renowned Companies & Institutions
Distribution agreement with one of the largest and most well regarded national fresh, organic and specialty food distributors in North America
Received key Clean Label Certifications for Toddler Nutrition Product
Posted by AGORACOM-Eric
at 12:37 PM on Thursday, January 7th, 2021
(CSE:XPHY / OTC:XPHYF / FSE:4XT)
Completed Successful SARS-CoV-2 RT-PCR Diagnostic Test Kit Validation
Secured Exclusive Psychedelic Drug Development Agreement
Appointed European Healthcare Executive to Board of Director
Engaged German Partner for Development of Psilocybin API Production
Announced Update on Contract Drug Delivery Program
Announced Update on Oral Thin Film Drug Delivery Program
Provided Update on Parkinson’s Transdermal Patch
Three Xphyto Divisions:
1. Vektor Pharma TF: World-class thin film drug delivery platforms for transdermal and oral dissolvable dosage forms
2. 3a-Diagnostics: Rapid, low-cost screening tests for pandemic and dental health applications
3. Xphyto Laboratories Inc.: Development of industrial production processes for emerging active pharmaceutical ingredients, including psychedelics and cannabinoid isolates
1. Vektor Pharma TF GmbH – Drug Delivery
100% owned XPhyto subsidiary
Global leader in design, testing and manufacture of therapeutic film drug delivery systems
Major pharma clients – past, present and future
Focused and nimble team – rapid turnaround on new opportunities
Versatile platform technology
Transdermal patches (TDS) – slow and steady release
Oral dissolvable film (ODF) sublingual strips – instant bioavailability
EU GMP facilities in Baden-Württemberg, Germany
Holder of numerous German narcotics import and manufacturing licences
XPhyto Drug Development Pipeline – Stage 1 & 2
Platform technology
Scalable product development pipeline
High-growth and new API opportunities
Neurological indications
Generic and hybrid-generic drug formulations
2. 3a-Diagnostics GmbH – Rapid Testing
XPhyto has an exclusive development, technology purchase and licence agreement
Specializing in the development, production, and marketing of low-cost point-of-care screening test systems:
COVID-19 rapid PCR Kit
COVID-19 disposable ultra-rapid test
Oral biosensors for the instant detection of bacterial and viral pathogens
Influenza A, H1N1 (swine flu), H5N1 (avian flu), Strep A, stomatitis, periimplantitis and periodontitis
Biosensor screening platform for high-throughput for identification of new biosensor targets for new biosensor products
Development partially funded by grants from the German Federal Ministry of Education and Research (BMBF)
As the name implies “PropTech” is a combination of two words and stands for “property technology.” As simple as that is, the implementation and importance of PropTech is anything but.
Like every other industry on the planet that is incorporating technology to create greater efficiencies and experiences, the commercial real estate market is no different and is seeing the rapid adoption of;
Artificial Intelligence
Machine learning
Big data
Internet of Things (IoT Sensors)
Cloud computing
To create cost savings by reducing and even eliminating existing costs, create greater efficiencies for the operation and maintenance of real estate assets, as well as, improve the design of new builds.
IMPACT OF COVID-19
The COVID-19 pandemic has served to significantly increased the demand for PropTech in the commercial real estate market as follows:
The need for solutions to get workers back into workplace buildings and offices. Specifically, the need to identify bacteria and viruses in indoor air quality, as well as, the ability to sanitize immediately and effectively.
The need to create even greater cost savings and efficiencies for real estate owners that will continue suffering losses until workers significantly return to the workplace.
WHY UNIVERSAL PROPTECH (UPI:TSXV)?
Whereas many companies are just now trying to capitalize on the opportunities presented in the current and massive future of PropTech, Universal PropTech Inc. (“UPI”) a diversified investment platform delivering healthy building solutions and services for building developers, owners and operators in Canada. More than just lip service, UPI has been successfully delivering its PropTech solutions for years, with revenues over the last 3 years as follows:
2017 – $13.8M
2018 – $13.7M
2019 – $15.9M
Headquartered in Toronto, UPI has offices across Canada including Halifax,Montreal, and Ottawa.
COMPANY HIGHLIGHTS
Used in Federal Government facilities for over 40 years
Provides real estate managers turnkey HVAC Building Controls design, equipment, installation and ongoing operations and maintenance services for Industrial, Commercial, Institutional and Multi-residential customers
Already possesses under-utilized IP in building controls to add in additional monitoring inputs and equipment controls
Diverse revenue streams via products, installations and ongoing
Key strategic partnerships afford the ability to monitor real-time utility meters, key BAS and systems data in a building.
Team has the capability to make sense of this data and apply advanced web tools to make recommendations to fine tune a building, saving from 5% to 15% of a facilities energy spend without capital expenditure
VCI offers the depth and breadth of Building Automation Systems (BAS) knowledge and products from the likes of Siemens and Honeywell to support building automation systems
As businesses return to the office, property managers must think about the design and safety of their buildings for occupants. Traditional cleaning methods are ineffective at preventing transmission. UV technology is able to sanitize all surfaces free from pathogens. UPI is capitalizing on this opportunity by building and acquiring UV technology as it is the best in the market to administer and integrate it into healthy buildings in Canada.
Posted by AGORACOM-JC
at 11:38 AM on Tuesday, December 15th, 2020
Innocan Pharma Corporation (INNO: CSE) (IP4:FSE) is developing the pharmaceutical guided missile to defeat coronavirus lung infections. The company specializes in the development of new drug platforms which combine unique properties of Cannabinoids.
3 Fully Operating Divisions For Investor Diversification
Innocan has 3 fully operating divisions to address the market for Cannabis products. As a Cannabis investor, why limit yourself to a Company with just one specialty, when Innocan offers you exposure to both the exploding world of cannabis pharma, as well as, a portfolio of patent-pending and launch ready consumer health products.
PHARMACEUTICAL – THE GUIDED MISSILE – Revolutionary technology targeting lungs infected with coronavirus or other viral infections.
CONSUMER RETAIL – DERMA COSMETICS – A premium derma cosmetics brand, manufacturing has commenced with distribution agreements in place.
OVER THE COUNTER (OTC) PRODUCTS FOR PAIN RELIEF – patent-pending CBD pain relief brand received FDA technical validation.
Global Manufacturing / Distribution Agreements
Endless Sky Inc. a Canadian large scale Cannabis extractor (Manufacturing and Distribution – Canada)
Active Therapeutics Ltd of Lancashire, United Kingdom (Distribution – UK and Ireland markets)
iAmHealth Distribution UG (Distribution – Germany)
Completed Trademark Registration in the EU, UK and Switzerland
Completion of the registration of its trademarks: Innocan Pharma, Relief & Go and SHIR in the EU, UK and Switzerland.
These trademarks represent Innocan’s OTC and derma cosmetic brand products that were recently launched in the German and UK markets.
Superior Management Team
In the small cap world, the jockey(s) that drive the horse are just as important as the horse itself. The InnoCan Leadership Group Is Incomparable In The Small Cap World, Comprised Of Leading Israeli Pharmaceutical Executives including:
Executive Chairman (Ron Mayron) was the CEO Of Teva Israel, one of the largest generic pharmaceutical companies in the world
Co-Founder & VP Business Development (Yoram Drucker) was the Founder of 2 NASDAQ Companies (Pluristem & Brainstorm)
Chief Technology Officer (Nir Avram) is a former member of the pharma innovation team at Perrigo, producer of OTC consumer goods and specialty pharma.
Chief Executive Officer (Iris Bincovich) has a proven track record in opening global markets, having managed hundreds of successful transactions in OTC, cosmetics and dermatology.
Together they have built one of the most formidable teams in the small cap cannabis world
Posted by AGORACOM-Eric
at 4:32 PM on Monday, December 14th, 2020
Fabled Silver Gold Corp. (TSXV: FCO)The Santa María Property is an under-explored, high-grade silver-gold project with significant exploration potential to expand mineral resources and identify new discoveries.
Fabled Silver Gold Company Highlights:
Commenced drilling on 100% option at Santa Maria Mine in Mexico
2020 NI 43-101 Resource of 3.2Moz Indicated and 1.1Moz Inferred in two primary veins
Two distinct Epithermal veins have been partially explored
Santa María Property is an under-explored, high-grade silver-gold project with significant exploration potential
19 significant vein structures exists within the property and provides future virgin exploration opportunities
Geophysical survey on the property and has successfully identified multiple targets for exploration and drilling
Santa Maria Deposit
High Grade silver-gold property located in mining friendly jurisdiction of Parrall, Mexico
The Parral mining district is situated in the center of the Mexican Silver belt, a district of epithermal silver gold mineralization
The belt has been recognized as producing more silver than any other equivalent are in the world
2018 PEA very supportive at current market prices
2 Mettalurgical Studies completed
Santa Maria vein structures provide many promising exploration and possibly future mining possibilities
The Santa Maria mine has never been systematically, or explored thoroughly with modern methods
The Asset: Santa Maria Mine 43-101
3.2Moz Indicated and 1.1Moz Inferred in two primary veins
High grade silver-gold property located in the mining friendly jurisdiction of Parrall, Chihuahua, Mexico.
The Parral mining district is situated in the centre of the Mexican silver belt epithermal silver-gold vein districts. The belt has been recognized as a significant metallogenic province, which has reportedly produced more silver than any other equivalent area in the world.
43-101 Technical Report completed on December 02, 2020 by Mineral Resources Engineering.
Significant vein structures within the property provides future exploration and mining opportunities.
Posted by AGORACOM-JC
at 12:09 PM on Monday, December 14th, 2020
Else Nutrition Holdings Inc. (BABY: TSXV) (BABYF: OTCQX) (0YF: FSE) is the award winning, plant-based nutrition company for small cap investors. The shift towards plant-based alternatives has opened the food market to new players, and created an opportunity for fast growth in a rapidly expanding space. Else has fully grasped at this opportunity as seen below.
Highlights include:
$CAD 30 Million In Cash
Launched 1st Commercial Product Into US Market
Backed By A $2.7 Billion Dollar Global Nutrition Company;
MOU For International Distribution Of Products
“Best Health” Award At Global Food Innovation Summit In Milan;
Awarded Patents In 22 Countries, 44 Countries Pending;
Executives & Advisors From Globally Renowned Companies & Institutions
Distribution agreement with one of the largest and most well regarded national fresh, organic and specialty food distributors in North America
Received key Clean Label Certifications for Toddler Nutrition Product
Received Key USDA Organic Certification
Else Nutrition’s Complete Nutrition for Toddlers ranked Top-Selling Product on Amazon’s Hot New Releases in Baby and Toddler Formula Category
Posted by AGORACOM-JC
at 3:38 PM on Friday, December 11th, 2020
Hollister Biosciences Inc. (HOLL:CSE) (HSTRF:OTC) (HOB: FRANKFURT) is a multi-state cannabis company with products in 230 dispensaries throughout California and over 80 dispensaries throughout Arizona, translating into the following great success:
REVENUES $CAD
Q1 $1,200,000
Q2 $11,500,000
Q3 $12,500,000
NOTE: Venom Extracts Acquisition Closed at the end of Q1.
TOTAL Q1/Q2/Q3
REVENUE $25.2M
On December 9 th, 2020, Venom achieved the second and final revenue milestone by generating in excess of CDN$40,000,000 of revenue calculated from January 1 st, 2020.
With the recent passage of Proposition 207 – legalizing the cultivation, sale and consumption of recreational cannabis in the state of Arizona Hollister is extremely well positioned to capitalize. This can best be summed up by quote of Venom Extracts Founder below:
“Seeing recreational Cannabis legalized in the state is an encouraging sign and is hopefully another step toward federal legalization. It should lead to increased tax revenue and job creation. The recreational cannabis market in Arizona could be valued at up to US $760 million by 2024 1 , significantly expanding the total addressable market for Cannabis in the state. We look forward to making our product line available to both the medical and recreational end user.” Shared Jacob Cohen, Founder of Venom Extracts, Hollister’s 100% owned subsidiary based in Arizona
In addition to organic sales, Hollister has several high-level partnerships that demonstrate how trusted the Company is within the industry, including:
Posted by AGORACOM-JC
at 3:12 PM on Friday, December 11th, 2020
Avicanna (AVCN: TSX) (AVCN: OTCQX) (0NN: FSE) is a vertically-integrated biopharmaceutical company developing and commercializing various cannabinoid-based products for the global marketplace.
Third Quarter Highlights
$882K in revenue, an increase of 24% from Q2-2020,
Double-digit growth, quarter over quarter from Q4-2019
In addition, the Company was able to reach a major milestone with the launch of certain products from its RHO Phyto product line in Canada and further diversified its revenue streams.
When we say vertically integrated, we mean it. Avicanna has 4 fully operating divisions to address the entire market for Cannabis products as follows:
1. The company has a full line of high end CBD based skin care products serving the consumer retail segment with Canadian distribution through Medical Cannabis by Shoppers, as well as global distribution later this year.
2. Avicanna’s superior medical cannabis line also features products distributed through Medical Cannabis by Shoppers, the online arm of Canada’s largest drugstore chain.
Recently Launched Medical Cannabis Program with its RHO Phyto™ Formulary Nationwide in Colombia (Read More)
Leveraging thesuccessful launch ofthe Company’sRHO Phyto™brandedadvancedmedical cannabisproduct linein Canada,the portfolio of preparations,including oil drops, sublingual sprays, capsules and topicals,are nowavailablenationwide inColombia through physician prescription.
The medical programincludesAvicanna’s 3pillarsaimed at setting the gold standard for medical cannabis in Colombia andotherLatin American markets, including
3. Avicanna also hosts a full pipeline of Pharmaceuticals in various stages of trials to address Dermatology, Psychiatry, Neurology, Pain and Oncology. Three of the company’s products are already as far as phase 2.
